Chlorofluorocarbon Inhalers Fully Phased Out This Year

FDA announced the phase-out will be completed by Dec. 31.

The U.S. Food and Drug Administration announced it will complete its phase-out of all inhaler medical products containing chlorofluorocarbons (CFCs) by Dec. 31, 2013. This complies with an international treaty to protect the ozone layer by phasing out the worldwide production of numerous substances, including CFCs, that contribute to ozone depletion.

Most products containing CFCs already have been phased out, but two prescription products still on the market -- Combivent Inhalation Aerosol and Maxair Autohaler, used by people with asthma or chronic obstructive pulmonary disease -- will no longer be available after 2013.

Boehringer Ingelheim Pharmaceuticals, Inc. developed the COMBIVENT® RESPIMAT® Inhalation Spray as a replacement for the COMBIVENT Inhalation Aerosol as the aerosol's phase-out neared. COMBIVENT RESPIMAT Inhalation Spray is approved by FDA for the treatment of patients with COPD on a regular aerosol bronchodilator who continue to have evidence of bronchospasm and who require a second bronchodilator.

"CFCs were used as propellants to move the drug out of inhalers so that patients can inhale the medicine," said Dr. Badrul Chowdhury, M.D., director of the Division of Pulmonary, Allergy and Rheumatology Products in FDA's Center for Drug Evaluation and Research. "For more than two decades, the FDA and EPA have collaborated to phase-out CFCs in inhalers, a process that included input from the public, advisory committees, manufacturers, and stakeholders."

The most widely used inhaler, albuterol CFC inhaler, was phased out in 2008 and replaced with inhalers that use propellants called hydrofluoroalkanes (HFAs).

"The EPA and FDA's partnership has facilitated a safe, gradual transition to CFC-free inhalers in the United States," said Drusilla Hufford, director of EPA's Stratospheric Protection Division of the Office of Air and Radiation. "This action is an important contribution to the global effort to repair the earth's protective ozone layer and save millions of lives through the prevention of skin cancer."

Download Center

  • EHS Buyer's Guide

    Download this buyer's guide to make more informed decisions as you're looking for an EHS management software system for your organization.

  • Online Safety Training Buyer's Guide

    Use this handy buyer's guide to learn the basics of selecting online safety training and how to use it at your workplace.

  • COVID Return-to-Work Checklist, Fall 2021

    Use this checklist as an aid to help your organization return to work during the COVID-19 pandemic in a safe and healthy manner.

  • SDS Buyer's Guide

    Learn to make informed decisions while searching for SDS Management Software.

  • Risk Matrix Guide

    Risk matrices come in many different shapes and sizes. Understanding the components of a risk matrix will allow you and your organization to manage risk effectively.

  • Industry Safe

Featured Whitepapers

OH&S Digital Edition

  • OHS Magazine Digital Edition - September 2021

    September 2021

    Featuring:

    • COMBUSTIBLE DUST
      Managing Combustible Dust and Risk Mitigation
    • PPE: CONSTRUCTION
      The Rising Popularity of Safety Helmets on the Jobsite
    • PPE: ELECTRICAL SAFETY
      Five Tips for a Successful Wear Trial
    • SAFETY & HEALTH
      Medical Surveillance Versus Medical Screening
    View This Issue